These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14824659)

  • 1. Comparative effects of ether, alcohol, tetraethylammonium, and priscoline in producing vasodilatation in peripheral vascular conditions.
    REEDY WJ
    J Lab Clin Med; 1951 Mar; 37(3):365-73. PubMed ID: 14824659
    [No Abstract]   [Full Text] [Related]  

  • 2. The locus of the peripheral vasodilator action of ethyl alcohol, tetraethylammonium and priscoline.
    SIEMS LL; ROTTENSTEIN HS
    Am J Med Sci; 1950 Dec; 220(6):649-54. PubMed ID: 14789768
    [No Abstract]   [Full Text] [Related]  

  • 3. Priscoline as an adjunct for the relief of vasospasm in peripheral vascular disease.
    LAGEN JB
    Am Pract Dig Treat; 1950 Jan; 1(1):50-3. PubMed ID: 15409628
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of priscoline on peripheral blood flow in normal subjects and patients with peripheral vascular disorders.
    VAN ITALLIE TB; CLARKE CW
    Circulation; 1951 Jun; 3(6):820-9. PubMed ID: 14848931
    [No Abstract]   [Full Text] [Related]  

  • 5. Vasodilation produced by etamon, priscol, body warming and spinal anesthesia in normal extremities.
    GREEN HD; OGLE BC
    Fed Proc; 1948 Mar; 7(1 Pt 1):43. PubMed ID: 18932720
    [No Abstract]   [Full Text] [Related]  

  • 6. Priscoline and etamon; a comparative study.
    SELIGMAN B
    South Med Surg; 1949 Dec; 111(12):368. PubMed ID: 15407625
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous ether and procaine in peripheral vascular diseases.
    DESSEL BH
    Marquette Med Rev; 1949 Jan; 14(2):52. PubMed ID: 18208147
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatality following the use of intravenous ether in the treatment of peripheral vascular disease.
    SEWALL S
    Bull Hosp Joint Dis; 1947 Apr; 8(1):33-7. PubMed ID: 20262610
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical evaluation of priscoline as a peripheral vasodilator.
    ZURROW HB; HENRIED PH; FISCHER I; SALAND G
    N Y State J Med; 1951 Apr; 51(8):1038-40. PubMed ID: 14827128
    [No Abstract]   [Full Text] [Related]  

  • 10. Reflex vasodilatation in treatment of peripheral vascular diseases.
    BURCH G; PHILLIPS J
    Am Heart J; 1961 Aug; 62():286. PubMed ID: 13688899
    [No Abstract]   [Full Text] [Related]  

  • 11. Priscoline and arteriosclerotic peripheral vascular disease.
    ROGERS MP
    Geriatrics; 1949; 4(5):315-9. PubMed ID: 18138392
    [No Abstract]   [Full Text] [Related]  

  • 12. An evaluation of the ability of priscoline, regitine, and roniacol to overcome vasospasm in normal man; estimation of the probable clinical efficacy of these drugs in vasospastic peripheral vascular disease.
    GREEN HD; GOBEL WK; MOORE MJ; PRINCE TC
    Circulation; 1952 Oct; 6(4):520-8. PubMed ID: 12979064
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of priscoline on digital blood flow in normal subjects and patients with peripheral arterial insufficiency.
    VAN ITALLIE TB; CLARKE CW
    Bull N Y Acad Med; 1951 Jun; 27(6):394. PubMed ID: 14839386
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of priscol (2-benzyl-4,5-imidazoline hydrochloride) in the treatment of peripheral vascular diseases.
    FRANK N; STRAZZA JA; HELSPER JT
    Ann Intern Med; 1951 Jul; 35(1):19-38. PubMed ID: 14847446
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of some psychopharmacological agents, pronethalol and atropine on the vasodilatation of the eye bulb of rabbit due to local application of reserpine and tolazoline.
    Krnjević H; Tomljanović D
    Arzneimittelforschung; 1968 Nov; 18(11):1425-6. PubMed ID: 4387835
    [No Abstract]   [Full Text] [Related]  

  • 16. The vasodilator effects of priscoline in patients with ischemic extremities.
    ROTTENSTEIN H; HORWITZ O; MONTGOMERY H; SAYEN A; SIEMS LL
    Am J Med Sci; 1951 Jun; 221(6):661-6. PubMed ID: 14829467
    [No Abstract]   [Full Text] [Related]  

  • 17. Intra-arterial and oral priscoline; a clinical report.
    WILSON JL; QUASH ET
    Am J Surg; 1951 Mar; 81(3):336-40. PubMed ID: 14819480
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of priscoline on the clearance of radiosodium from muscle and skin of man in normal and diseased limbs.
    FREUND J; WISHAM LH; YALOW RS
    Circulation; 1953 Jul; 8(1):89-97. PubMed ID: 13059867
    [No Abstract]   [Full Text] [Related]  

  • 19. "Priscol" in treatment of peripheral vascular disease.
    GOODWIN JF; KAPLAN S
    Br Med J; 1951 May; 1(4715):1102-7. PubMed ID: 14830849
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of priscol on peripheral vascular diseases, hypertension and circulation in patients.
    GRIMSON KS; REARDON MJ
    Ann Surg; 1948 May; 127(5):968-91. PubMed ID: 18865356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.